Trials routes of administration. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy11

Liver Brain Kidney Lung Spleen Cells, Cultured Feces Bile Intestines Neurons Cell Line, Tumor

Organisms18

Rats, Sprague-Dawley Rats, Wistar Mice, Inbred C57BL Mice, Inbred BALB C Dogs Rats, Inbred Strains Mice, Inbred ICR Rats, Inbred F344 Rabbits Mice, Inbred Strains Mice, Knockout Swine Animals, Newborn Macaca mulatta Mice, Nude Mice, Transgenic Sheep Adenoviridae

Diseases20

Disease Models, Animal Neoplasms Body Weight Pain Recurrence Acute Disease Chronic Disease Breast Neoplasms Lung Neoplasms Disease Progression Inflammation Myocardial Infarction Stroke Vomiting Neoplasms, Experimental HIV Infections Hypertension Hemorrhage Nausea Drug-Related Side Effects and Adverse Reactions

Chemicals and Drugs71

Placebos Antineoplastic Agents Recombinant Proteins Drug Combinations Plant Extracts Antibodies, Monoclonal Morphine Analgesics, Opioid Anti-Bacterial Agents Analgesics Blood Glucose RNA, Messenger Enzyme Inhibitors Piperidines Delayed-Action Preparations Anti-Inflammatory Agents Ethanol Estradiol Prodrugs Adjuvants, Immunologic Insulin Cytokines Pyridines Piperazines Hypoglycemic Agents Glucocorticoids Cyclophosphamide Drugs, Chinese Herbal Biological Markers Dexamethasone Antioxidants Fluorouracil Analgesics, Non-Narcotic Pyrazoles Immunoglobulin G Immunosuppressive Agents Cocaine Naloxone Anti-Inflammatory Agents, Non-Steroidal Hydrocortisone Narcotic Antagonists Doxorubicin Cisplatin Sulfonamides Tumor Necrosis Factor-alpha Drug Carriers Nitric Oxide Antihypertensive Agents Testosterone Dopamine Suppositories Progesterone Lipopolysaccharides Methotrexate Antineoplastic Agents, Phytogenic Quinolines Paclitaxel Vasodilator Agents Neuroprotective Agents Aspirin Indoles Erythropoietin Imidazoles Central Nervous System Stimulants Gonadotropin-Releasing Hormone Growth Hormone Polyethylene Glycols Triazoles Antidepressive Agents Anti-Infective Agents Antibodies, Monoclonal, Humanized

Analytical, Diagnostic and Therapeutic Techniques and Equipment97

Clinical Trials as Topic Administration, Oral Drug Administration Routes Drug Administration Schedule Injections, Intravenous Double-Blind Method Treatment Outcome Administration, Intranasal Clinical Trials, Phase III as Topic Injections, Subcutaneous Injections, Intraperitoneal Research Design Injections, Intramuscular Clinical Trials, Phase II as Topic Disease Models, Animal Clinical Trials, Phase I as Topic Administration, Rectal Infusions, Intravenous Controlled Clinical Trials as Topic Placebos Administration, Topical Prospective Studies Cross-Over Studies Random Allocation Drug Therapy, Combination Administration, Cutaneous Area Under Curve Administration, Intravenous Follow-Up Studies Single-Blind Method Administration, Sublingual Analysis of Variance Injections, Intraventricular Clinical Protocols Administration, Inhalation Patient Selection Blood Pressure Pilot Projects Body Weight Injections Early Termination of Clinical Trials Pain Measurement Multicenter Studies as Topic Antineoplastic Combined Chemotherapy Protocols Infusions, Parenteral Combined Modality Therapy Chromatography, High Pressure Liquid Metabolic Clearance Rate Injections, Spinal Survival Analysis Drug Approval Drug Evaluation, Preclinical Drug Evaluation Injections, Intradermal Feasibility Studies Administration, Intravaginal Phytotherapy Risk Factors Severity of Illness Index Heart Rate Injections, Intra-Arterial Organ Size Sample Size Drug Delivery Systems Reproducibility of Results Delayed-Action Preparations Genetic Therapy Questionnaires Self Administration Clinical Trials, Phase IV as Topic Survival Rate Retrospective Studies Immunohistochemistry Risk Assessment Body Temperature Disease-Free Survival Models, Biological Vaccination Models, Animal Administration, Buccal Drug Carriers Statistics, Nonparametric Intubation, Gastrointestinal Data Interpretation, Statistical Prognosis Leukocyte Count Neoplasms, Experimental Immunization Magnetic Resonance Imaging Premedication Infusion Pumps Lethal Dose 50 Neoplasm Transplantation Reference Values Exercise Therapy Microdialysis Enzyme-Linked Immunosorbent Assay

Psychiatry and Psychology4

Behavior, Animal Motor Activity Pain Patient Compliance

Phenomena and Processes32

Time Factors Dose-Response Relationship, Drug Biological Availability Half-Life Area Under Curve Drug Interactions Tissue Distribution Blood Pressure Pregnancy Body Weight Motor Activity Pain Metabolic Clearance Rate Drug Tolerance Heart Rate Organ Size Hemodynamics Genetic Vectors Intestinal Absorption Eating Kinetics Drug Synergism Absorption Biotransformation Body Temperature Stereoisomerism Diet Apoptosis Signal Transduction Leukocyte Count Lethal Dose 50 Therapeutic Equivalency

Disciplines and Occupations5

Research Design Outcome Assessment (Health Care)Immunohistochemistry Evidence-Based Medicine Chemistry, Pharmaceutical

Anthropology, Education, Sociology and Social Phenomena4

United States Food and Drug Administration Drug Approval Quality of Life United States Department of Veterans Affairs

Technology, Industry, Agriculture2

Dietary Supplements Polyethylene Glycols

Humanities1

Quality of Life

Information Science3

Questionnaires Survival Rate Data Interpretation, Statistical

Named Groups1

Infant, Newborn

Health Care46

Clinical Trials as Topic Double-Blind Method United States Food and Drug Administration Treatment Outcome Clinical Trials, Phase III as Topic Clinical Trials, Phase II as Topic Clinical Trials, Phase I as Topic Controlled Clinical Trials as Topic Prospective Studies Cross-Over Studies Random Allocation Area Under Curve Follow-Up Studies Single-Blind Method Analysis of Variance Clinical Protocols Patient Selection Pilot Projects Early Termination of Clinical Trials Multicenter Studies as Topic Clinical Trials Data Monitoring Committees Survival Analysis Feasibility Studies Cost-Benefit Analysis Risk Factors Severity of Illness Index Sample Size Reproducibility of Results Outcome Assessment (Health Care)Questionnaires Clinical Trials, Phase IV as Topic Survival Rate Retrospective Studies Patient Compliance Safety Risk Assessment Disease-Free Survival Vaccination Placebo Effect Statistics, Nonparametric Age Factors Data Interpretation, Statistical Intention to Treat Analysis Immunization United States Department of Veterans Affairs Patient Satisfaction

Geographicals1

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Named Groups Health Care Geographicals

Clinical Trials as Topic Administration, Oral Drug Administration Routes Drug Administration Schedule Time Factors Injections, Intravenous Double-Blind Method Dose-Response Relationship, Drug United States Food and Drug Administration Treatment Outcome Administration, Intranasal Rats, Sprague-Dawley Clinical Trials, Phase III as Topic Injections, Subcutaneous Injections, Intraperitoneal Research Design Injections, Intramuscular Clinical Trials, Phase II as Topic Disease Models, Animal Rats, Wistar Clinical Trials, Phase I as Topic Administration, Rectal Infusions, Intravenous Controlled Clinical Trials as Topic Placebos Biological Availability Administration, Topical Prospective Studies Mice, Inbred C57BL Cross-Over Studies Random Allocation Half-Life Drug Therapy, Combination Administration, Cutaneous Area Under Curve Liver Antineoplastic Agents Administration, Intravenous Follow-Up Studies Single-Blind Method Mice, Inbred BALB C Drug Interactions Administration, Sublingual Tissue Distribution Analysis of Variance Injections, Intraventricular Clinical Protocols Administration, Inhalation Neoplasms Dogs Patient Selection Blood Pressure Brain Pregnancy Pilot Projects Recombinant Proteins Rats, Inbred Strains United States Body Weight Drug Combinations Injections Early Termination of Clinical Trials Pain Measurement Multicenter Studies as Topic Antineoplastic Combined Chemotherapy Protocols Kidney Behavior, Animal Infusions, Parenteral Plant Extracts Combined Modality Therapy Antibodies, Monoclonal Clinical Trials Data Monitoring Committees Lung Motor Activity Morphine Pain Chromatography, High Pressure Liquid Metabolic Clearance Rate Analgesics, Opioid Injections, Spinal Drug Tolerance Survival Analysis Anti-Bacterial Agents Drug Approval Drug Evaluation, Preclinical Drug Evaluation Injections, Intradermal Analgesics Feasibility Studies Administration, Intravaginal Quality of Life Cost-Benefit Analysis Recurrence Phytotherapy Blood Glucose Risk Factors Severity of Illness Index Mice, Inbred ICR Heart Rate Injections, Intra-Arterial

No FAQ available that match "trials routes of administration"